Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Dec-20 4:05 PM View:  | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 28,125 | -- | -- | 16% 174.82K to 202.94K | |
| 17-Dec-20 4:05 PM View: | Lipocine Inc. (LPCN) | 16-Dec-20 | Market Option Sale (Planned) | 8,437 | $1.35 | $11,390.00 | (4%) 202.94K to 194.5K | |
| 08-Dec-20 4:50 PM View: | Lipocine Inc. (LPCN) | 05-Dec-20 | Option Exercise | 70,754 | -- | -- | 68% 104.06K to 174.82K | |
| 08-Dec-20 4:50 PM View: | Lipocine Inc. (LPCN) | 04-Dec-20 | Option Exercise | 57,500 | -- | -- | 90% 63.81K to 121.31K | |
| 08-Dec-20 4:50 PM View: | Lipocine Inc. (LPCN) | 04-Dec-20 | Market Option Sale (Planned) | 17,250 | $1.57 | $27,023.80 | (14%) 121.31K to 104.06K | |
| 06-Dec-19 10:42 AM View: | Lipocine Inc. (LPCN) | 04-Dec-19 | Option Exercise | 57,500 | -- | -- | 244% 23.56K to 81.06K | |
| 06-Dec-19 10:42 AM View: | Lipocine Inc. (LPCN) | 04-Dec-19 | Market Option Sale (Planned) | 17,250 | $0.41 | $7,075.95 | (21%) 81.06K to 63.81K | |
| 02-Jan-18 6:15 PM View: | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 9,375 | -- | -- | 55% 17.0K to 26.38K | |
| 02-Jan-18 6:15 PM View: | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 2,813 | $3.47 | $9,773.49 | (11%) 26.38K to 23.56K | 51% |
| 18-Sep-13 5:09 PM View: | Lipocine Inc. (LPCN) | 16-Sep-13 | Grant | 12,000 | -- | -- | 100% 0 to 12.0K | |
| 30-May-13 9:46 PM View: | Innovus Pharmaceuticals, Inc. (NONE) | 28-May-13 | Grant | 750,000 | -- | -- | 100% 0 to 750.0K | |
| 02-Feb-05 2:39 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 01-Feb-05 | Market Sale (Planned) | 898 | $16.19 | $14,539.50 | (100%) 0.9K to 0 | (77%) |
| 02-Feb-05 2:39 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 31-Jan-05 | Acquisition (other) | 898 | $14.02 | $12,594.40 | 100% 0 to 0.9K | |
| 04-Aug-04 10:00 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 03-Aug-04 | Market Sale (Planned) | 348 | $17.95 | $6,246.60 | (100%) 0.35K to 0 | (60%) |
| 04-Aug-04 10:00 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 02-Aug-04 | Acquisition (other) | 348 | $15.57 | $5,419.06 | 100% 0 to 0.35K | |
| 04-Feb-04 10:00 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 03-Feb-04 | Market Sale (Planned) | 651 | $32.99 | $21,475.80 | (100%) 0.65K to 0 | 13% |
| 04-Feb-04 10:00 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 02-Feb-04 | Acquisition (other) | 651 | $17.48 | $11,382.40 | 100% 0 to 0.65K |